Success Metrics

Clinical Success Rate

97.3%

Based on 36 completed trials

Completion Rate

97%(36/37)

Active Trials

25(28%)

Results Posted

31%(11 trials)

Terminated

1(1%)

Phase Distribution

Ph phase_1

10%

Ph not_applicable

74%

Ph phase_2

Ph early_phase_1

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution83 total trials

Early Phase 1First-in-human

5(6.0%)

Phase 1Safety & dosage

9(10.8%)

Phase 2Efficacy & side effects

3(3.6%)

Phase 4Post-market surveillance

1(1.2%)

N/ANon-phased studies

65(78.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.7%

36 of 43 finished

Non-Completion Rate

16.3%

7 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(36)

Completed(36)

Terminated(7)

Other(9)

Detailed Status

Completed36

Recruiting22

Not yet recruiting9

unknown9

Withdrawn6

Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

97.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 15 (6.0%)

Phase 19 (10.8%)

Phase 23 (3.6%)

Phase 41 (1.2%)

N/A65 (78.3%)

Trials by Status

recruiting2225%

enrolling_by_invitation22%

not_yet_recruiting910%

unknown910%

completed3641%

active_not_recruiting33%

terminated11%

withdrawn67%

Recent Activity

25 active trials

Showing 5 of 88

completednot_applicable

Development of Non-Invasive Brain Stimulation Techniques

NCT03351764

completedearly_phase_1

Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

NCT00453505

not_yet_recruitingnot_applicable

Clinical Trials (88)

Showing 20 of 88 trialsScroll for more

NCT03351764Not Applicable

Development of Non-Invasive Brain Stimulation Techniques

Completed

NCT00453505Early Phase 1

Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

Completed

NCT07842302Not Applicable

Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy.

Not Yet Recruiting

NCT07680140Phase 4

Biomarker-Guided Antidepressant Selection

Recruiting

NCT07785102Early Phase 1

Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101

Not Yet Recruiting

NCT04179435Not Applicable

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

Completed

NCT07039370Not Applicable

Molecular Signatures of TMS Response in Treatment-Resistant Depression

Recruiting

NCT06612190Not Applicable

Evaluation on Visual Outcome of TMS

Active Not Recruiting

NCT06597942Phase 1

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Recruiting

NCT02363296Not Applicable

Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)

Completed

NCT07770451Not Applicable

Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism

Not Yet Recruiting

NCT07593222Phase 1

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

Not Yet Recruiting

NCT07595185Not Applicable

Effects of Accelerated rTMS on Sleep Architecture in Chronic Insomnia Disorder

Enrolling By Invitation

NCT06835699Phase 1

Psilocybin Brain Stimulation and Imaging Pilot Study

Completed

NCT07460947Phase 1

A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder

Recruiting

NCT07547319Not Applicable

Effects of Accelerated rTMS on Cognitive Function

Recruiting

NCT07147218Not Applicable

Accelerated TMS for MDD

Active Not Recruiting

NCT07570212Not Applicable

Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders

Recruiting

NCT06548113Not Applicable

Sensory Synchronized Imaging and Neuromodulation

Not Yet Recruiting

NCT06824415Not Applicable

Sleep TMS for Depression

Recruiting

Drug Details

Intervention Type: DEVICE
Total Trials: 88